Call for Abstract

2nd Annual Summit on Cell Therapy and Stem Cell Research , will be organized around the theme “Bridging the Gap from Basic Cell Science to Advanced Cellular Therapies for a Better Life”

Cell Therapy & Stem Cell Research 2018 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Cell Therapy & Stem Cell Research 2018

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Cell therapy or cytotherapy is the transfer of cells into a patient with a goal of improving the disease.  From beginning blood transfusions were considered to be the first type of cell therapy to be practised as routine. Later, Bone marrow transplantation has also become a well established concept which involves treatment of many kind of blood disorders including anemia, leukemia, lymphyoma and rare immunodeficiency diseases. Alternative medical practitioners perform cell therapy in the form of several different names including xenotransplant therapy, glandular therapy, and fresh cell therapy. It has been claimed by the proponents of cell therapy that it has been used successfully to repair spinal cord injuries, strengthen weaken immune system, treats autoimmune diseases like AIDS, help patients with neurological disorders like Alzheimer’s disease, parkinson’s disease and epilepsy. 

  • Track 1-1Cell therapy products
  • Track 1-2Cell-based assays
  • Track 1-3Regeneration of Spinal Nerve Cells
  • Track 1-4Extracellular vesicles as the next generation cell therapy
  • Track 1-5Advances in Hematopoietic stem cell transplantation
  • Track 1-6Advantages and disadvantages of cell therapy

Gene therapy basically involves the introduction or alteration of genetic material within a cell  or organism with an intention of curing the disease. Both cell therapy and gene therapy are overlapping fields of biomedical  research with the goals of repairing the direct cause of genetic diseases in DNA or cellular population respectively. The discovery of recombinant DNA technology in the 1970s provided tools to efficiently develop gene therapy. Scientists use these techniques to readily manipulate viral genomes, isolate genes and identify mutations involved in human disease, characterize and regulate gene expressions, and engineer various viral and non viral vectors. Various long term treatments for anemia, haemophilia, cystic fibrosis, muscular dystrophy, Gauscher’s disease, lysosomal storage diseases, cardiovascular diseases, diabetes and diseases of bones and joints are resolved through successful gene therapy and are elusive today. 

  • Track 2-1Gene therapy products
  • Track 2-2Process of gene therapy
  • Track 2-3Various types of gene therapy
  • Track 2-4Different vectors for gene therapy
  • Track 2-5Gene therapy for Diabetes
  • Track 2-6Gene therapy for Sickle- Cell Disease
  • Track 2-7Gene therapy for age related macular degeneration

Molecular Medicine is a branch of medicine that develops ways to diagnose and treat diseases by understanding the ways genes, proteins and other cellular molecules work. It is a broad field where physical, chemical, biological, bioinformatics, and medical techniques are used to describe molecular structures and mechanisms, identify fundamental molecular and genetic errors of the disease, and to develop molecular interventions to correct them.  Molecular Medicine has now a days proved to be an exciting field of research as some of the recent advancements has led to improved clinical benefits for human health. These are LPS- induced inflammatory response is suppressed by Wnt inhibitors, Dickkopf-1 and LGK974, Selective inhibition of Ebola entry with selective estrogen receptor modulators by disrupting the endolysosomal calcium, ApoA-IV improves insulin sensitivity and glucose uptake in mouse adipocytes via PI3K-Akt Signalling and many more.   

  • Track 3-1Molecular Medicine for Sickle cell anemia
  • Track 3-2Orthomolecular Medicine
  • Track 3-3Molecular Medicine for Cancer
  • Track 3-4Molecular Medicine for Asthma
  • Track 3-5Molecular Medicine for neurodegenerative diseases

Due to rapidly advancing field of cancer immunology in past few years, there has been production of several new methods of treating cancer called Immunotherapies. Immunotherapy is a type of treatment that increases the strength of immune response against tumors either by stimulating the activities of specific components of immune system or by counteracting signals produced by cancer cells that suppress immune responses. Some types of immunotherapy are also called as biologic therapy or biotherapy. Recent advancements in cancer immunotherapies have provided new therapeutic approaches. These include tumor-associated macrophages as treatment targets in oncology, in-situ activation of platelets with checkpoint inhibitors for post-surgical cancer immunotherapy, immune checkpoint blockade and associated endocrinopathies and many more. 

  • Track 4-1Monoclonal antibodies
  • Track 4-2Immune checkpoint inhibitors
  • Track 4-3Immune system modulators
  • Track 4-4Cancer Vaccines
  • Track 4-5Other, non-specific immunotherapies

Genetic Medicine or Medical Genetics is the branch of medicine that differs from human genetics, and involves the diagnosis and management of hereditary disorders. Human genetics may or may not apply to medicine, but medical genetics refers to the application of genetics to medical care. Genetic Medicine basically involves different areas such as gene therapy, personalized medicine, predictive medicine and the rapidly emerging new medical specialty. Now a days, medical genetics has wide range of scopes in many conditions involving birth defects and dysmorphology, autism, mental retardation, skeletal dysplasia, mitochondrial disorders, cancer genetics, connective tissue disorders and some more.  

  • Track 5-1Clinical Genetics
  • Track 5-2Metabolic Genetics
  • Track 5-3Cytogenetics
  • Track 5-4Molecular Genetics
  • Track 5-5Mitochondrial Genetics

According to National Institute of Health (NIH), Clinical Research is defined in 3 ways i.e. (1) Patient oriented research. Research which is conducted with human subjects (or on material of human origin such as tissues, specimens and cognitive phenomena) for which an investigator (or colleague) directly interacts with human subjects. This definition excludes the in vitro studies that utilize human tissues that cannot be linked to a living individual. Patient oriented research involves: (a) therapeutic interventions, (b) mechanisms of human disease, (c) clinical trials, or (d) development of new technologies. (2) Epidemiological and behavioural investigations. (3) Outcomes research and health services research.

Translational Research on the other hand includes two areas. One is the process of utilizing discoveries generated in the laboratory during research, and in preclinical studies, to the development trials and studies in humans. Second arena of translation concerns on research aimed at enhancing the adoption of best practices in the community. An important part of translational science also includes cost effectiveness of prevention and treatment strategies.  

  • Track 6-1Clinical Trials for drugs, devices and procedures
  • Track 6-2Clinical Trials in cell and gene therapies
  • Track 6-3Clinical biostatistics
  • Track 6-4Clinical research ethics
  • Track 6-5Translational medicine for ageing
  • Track 6-6Translational medicine for cancer research
  • Track 6-7Translational medicine for Cell & Gene Therapy

Cell Therapy Bioprocessing activity mainly focuses to accelerate the safe, cost- effective translations and clinical efficacious of cell therapies into commercial products. This activity covers the entire range of cell therapy activities as well as tissue engineering. In order to succeed, commercial success of at least a few late-stage products are required to develop which will be funded to develop next generation tools and technologies for this field. Recent achievements include, preclinical filing for Phase 1 clinical trials for cell therapy in acute spinal cord injury, clinical proof of concept studies in tissue- engineered trachea, clinical trials for tissue-engineered larynx and routine clinical practice in the regeneration of corneas. The future research priorities will focus on novel cell and bioprocess engineering techniques in order to improve the manufacturing efficacy and methods for health technology assessment to support rapid clinical adoption of new cell therapies.  

  • Track 7-1Upstream process and downstream process development for gene therapies
  • Track 7-2Technologies & Methodologies for Analytical Development
  • Track 7-3Manufacturing strategies for cell therapy products
  • Track 7-4Therapeutic area clinical update for cell therapy products
  • Track 7-5Opportunities and challenges for cell therapy commercialization
  • Track 7-6Regulatory challenges for the clinical manufacture of cell & gene therapy medicinal products

Cell  and Gene Therapy products manufacturing focuses on various strategies like the manufacturing process must protect the product, patient, should focus on product characterization, process control, high throughput and parallel processing to achieve scale. The process/analytical development throughout clinical trials involve ongoing, iterative development of manufacturing process and characterization of profile and FDA expecting increasing control and characterization as clinical development progresses. Steps involved in individualized manufacturing and running in parallel for high throughput involves cell selection, expansion, activation, centrifugation and cryopreservation. 

  • Track 8-1Funding & Investment in the Cell & Gene Therapy field
  • Track 8-2Process Development and Scale-up for the product
  • Track 8-3Development Pathways for MSC Based Production
  • Track 8-4Cell counting and cell sorting technologies

Rare diseases are life-threatening or chronically debilitating conditions, affecting no more than 5 in 10,000 persons in the European Community according to the Regulation (EC) N. 141/2000 of the European Parliament and of the Council. It is estimated that between 6000 to 8000 distinct rare diseases affect up to 6% of the total EU population. Therefore, these conditions can be considered rare if taken individually but they affect a significant proportion of the European population when considered as a single group. Several initiatives have been taken at international, European and national level to tackle public health as well as research issues related to diagnosis, prevention, treatment and surveillance of these diseases. An Orphan drug can be defined as the one that is used to treat an orphan disease. An orphan disease in USA is defined as the one that affects fewer than 200000 individuals, but in Japan the number is 50,000 and in Australia is 2000. In past 20 years efforts have been made to encourage companies to develop orphan drugs. The Orphan Drug Act in the USA (1983) was succeeded by similar legislation in Japan (1985), Australia (1997), and the European Community (2000). The encouragement takes three forms: tax credits and research aids, simplification of marketing authorization procedures, and extended market exclusively. 

  • Track 9-1Craniofacial Morphogenesis
  • Track 9-2Diverse Immunotherapy Approaches
  • Track 9-3T cell immunotherapy
  • Track 9-4Gene, stem cell and future therapies for orphan diseases
  • Track 9-5Rare Diseases and Regenerative Medicine

Stem cells can self renew themselves and differentiate or develop into more specialised cells. They are the foundation for every organ and tissue in our body.  Due to this ability of the stem cells, they have tremendous promise to help us understand and treat a wide range of diseases, injuries and other health related problems. Bone marrow transplantation is the most widely used stem cell therapy , but some of the therapies are derived from umbilical cord blood are also in use today. Likewise, blood stem cells are used to treat diseases of blood, a therapy that has saved thousands of lives of children with leukemia. Some bone, skin and corneal (eye) injuries and diseases can be treated by grafting or implanting tissues and the healing process relies on stem cells with implanted tissue. Regenerative medicines aims to replace tissues or organs that have been damaged by disease, trauma, or congenital issues which is in contrast to the current clinical strategy that focuses primarily on treating the symptoms. These regenerative medicines have wide appropriateness in treating degenerative scatters including dermatology, cardio vascular, and neuro degenerative diseases. Cell treatment is the quickest developing fragment of regenerative drug and this undeveloped cell treatment is making up the biggest part of this business sector.   

  • Track 10-1Stem cell preservation and biobanks
  • Track 10-2Collecting and Banking a Quality Cord Blood Product
  • Track 10-3Epigenetic Regulation of Stem Cell Differentiation
  • Track 10-4Clinical Applications of Stem Cells & Stem Cell Therapy
  • Track 10-5Translation Opportunities in Stem Cell Research
  • Track 10-6Medical devices and artificial organs
  • Track 10-7Anti-ageing therapies
  • Track 10-8Ethical and legal issues

Stem cell technology is now a days a rapidly emerging field that combines the efforts of cell biologists, clinicians and geneticists. This offers a hope for effective treatment for a variety of malignant and non-malignant diseases. Research has also shown that other than hematopoietic stem cells there are stem cells present in other sites. Hematopoietic stem cells research has made much progress than research in solid tissue stem cells. But the tissue stem cells have proven to be ideal for cell replacement therapy as it has the ability to integrate into the tissue cytoarchitechture under the control of host microenvironment and developmental cues. Moreover, it has also been found that transferring gene into hematopoietic stem cells may allow treatment of genetic diseases. Neurone replacement is done by using neuronal stem cells in disorders such as Parkinson’s and Huntingdon’s diseases. As a result of integrative effort with clinical applications of manipulated stem cells combining developments in transplantation and gene therapy, stem cell technology is advancing. 

  • Track 11-1Hematopoietic stem cells and gene therapy
  • Track 11-2Challenges in transplanting stem cells
  • Track 11-3Cord blood stem cell banking
  • Track 11-4Cord stem cells for heart failure
  • Track 11-5Stem cell for nerve function
  • Track 11-6Stem cells for hair growth
  • Track 11-7Stem cells for aged hearts
  • Track 11-8Regenerative therapy for muscular disorders
  • Track 11-9CRISPR and Stem cells

Cancer is a process where the cells grow aberrantly and this growth of cancer cells results in damage of normal tissues, causing loss of function and often pain. The cancer therapeutic drugs are those drugs that block the growth and spread of cancer by interfering with specific molecules (molecular targets) that are involved in the growth, progression and spread of cancer. Moreover, gene therapy approaches may be designed to directly kill tumor cells using tumor killing viruses, or through the introduction of genes termed as suicide genes into the tumor cells. The Food and Drug Administration (FDA) has approved many cancer therapies in order to treat specific types of cancers. To develop targeted therapies it requires the identification of good targets that is, those targets that play a key role in cancer cell growth and survival.  One way to identify potential targets is to compare the amounts of individual proteins in cancer cells with those present in normal cells. Gene silencing has also been designed to inhibit the expression of specific genes which are activated or over expressed in cancer cells and can drive tumor growth, blood vessel formation and allow resistance for chemotherapy

  • Track 12-1Cancer gene therapy
  • Track 12-2Nano methods to target cancer cells
  • Track 12-3Nano micro fluids in cell therapy
  • Track 12-4Nano materials and nano engineering
  • Track 12-5Molecular medicines

Nuclear medicine is a branch of medical imaging that involves the application of radioactive substances called radiotracers that are generally injected into the bloodstream, inhaled or swallowed. The radiotracer then travels through the area being examined and gives off energy in the form of gamma rays, which are detected by a special camera and a computer to create images of inside the body. It is used to diagnose or determine the severity of or treat different types of diseases like many types of cancers, heart disease, neurological disease, gastrointestinal disease, and other abnormalities inside the body. As nuclear medicine techniques are able to identify molecular activity within the body, they offer the capability to detect diseases in its very early stages as well as a patient’s immediate response to therapeutic interventions. There are two most common imaging methods in nuclear medicine, one is Single Photon Emission Computed Tomography or SPECT and the other is Positron Emission Tomography or PET scans.  

  • Track 13-1Radionuclides
  • Track 13-2Radioimmunotherapy
  • Track 13-3Interventional Nuclear Medicine
  • Track 13-4Nuclear Imaging

Biomedical engineering can be defined as the application of design concepts and engineering principles to medicine and biology for healthcare or therapeutic purposes. It has various applications which include development of biocompatible prostheses, regenerative tissue growth, various diagnostic and therapeutic medical devices, pharmaceutical drugs and therapeutic biological. In recent times, advancements in cell engineering, imaging and screening has reached a great height in the field of science & technology and also in the business world. It has attracted many scientists from academia and also established or emerging companies in the field to present their latest scientific achievements and exciting technological solutions through presentations in several sessions. This has helped in improving the scientific knowledge among the people, scientists, researchers and exhibitors from all over the world thus enhancing their scientific curiosity and providing robust solutions against technological issues. 

  • Track 14-1Advancements in Bioinformatics
  • Track 14-2Advances in Biomaterial science, Biomedical optics, Tissue engineering
  • Track 14-3Advances in Genetic engineering, Neural engineering and Pharmaceutical engineering
  • Track 14-4New imaging and microscopy tools
  • Track 14-53D cell culture and organoids
  • Track 14-6In vivo cell- based assays

Synthetic Biology is one of the emerging field of research that can be broadly described as the design and construction of novel artificial biological pathways, organisms or devices or the redesigning of existing natural biological systems. 

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Technology is one of the most powerful yet simple tool for genome editing. It helps and allows researchers to easily alter DNA sequences and modify gene functions. It has many potential applications that include correcting genetic disorders, treating and preventing the spread of diseases and improving crops. CRISPR popularly used as CRISPR-Cas9 where CRISPRs are specialized stretches of DNA and Cas9 is the protein which is an enzyme that acts like a pair of molecular scissors, capable of cutting DNA strands. The promise of CRISPR technology however raises ethical concerns as it is not 100% efficient. But the development of CRISPR-Cas9 has revolutionised the synthetic biology industry in today’s world, being a simple and effective gene editing tool. 

  • Track 15-1Synthetic Biology Applications
  • Track 15-2CRISPR-Cas9 for human health
  • Track 15-3CRISPR-Cas9 for crop research
  • Track 15-4CRISPR-Cas9 for Industrial biotechnology
  • Track 15-5CRISPR in Cancer
  • Track 15-6CRISPR in RNA editing and Biomedicine
  • Track 15-7Genetic modification of Human embryonic stem cells
  • Track 15-8Genetically modified immune cells control HIV Long-term